Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > Any thoughts on the past week’s trading?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Hideawayon Feb 17, 2021 9:52am
152 Views
Post# 32583431

RE:RE:RE:RE:RE:Any thoughts on the past week’s trading?

RE:RE:RE:RE:RE:Any thoughts on the past week’s trading?This is a very hard investment to keep in one's portfolio and many times I have resisted the urge to sell.What really is troubling is their inability to meet expectations,delay after delay.The vaccines being just one example.However,like the majority of investors it is the cancer trials that persuade me to hold.From what we know,the dlcbc results anticipated shortly should be good and if the other releases are positive,we should be heading North with the prospect of a Merck deal more probable.
GLTA
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities